SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AEROB) today announces that on 15 September 2010 the Board, by virtue of authorization by the shareholders’ meeting, decided to carry out a SEK 225 million directed issue of new shares and convertible bonds to Denmark-based Novo A/S, as well as a SEK 155.5 million new share issue with preferential rights to existing shareholders. The issue price and the conversion price of the convertible bonds are set at 13 and 41 per cent premium, respectively, to the closing share price on 15 September, 2010. The proceeds from the issue of new shares and convertible bonds will strengthen Aerocrine’s financial position and enable the company to drive the commercialization of its products.
